N87 Dysplasia of cervix uteri

Name of the Condition

• Dysplasia of Cervix Uteri
• ICD-10 Code: N87

Summary

Dysplasia of cervix uteri refers to abnormal cell growth on the surface of the cervix, which may indicate precancerous changes. This condition is often detected through routine screening and is categorized by the degree of cellular abnormality. Early detection and management are key to preventing progression to cervical cancer.

Causes

Dysplasia of the cervix is primarily caused by persistent infection with high-risk human papillomavirus (HPV) types. Other factors, such as smoking, weakened immune systems, or long-term use of oral contraceptives, may contribute to its development. In some cases, the exact cause remains unclear.

Risk Factors

• HPV infection: Persistent infection with high-risk HPV strains.
• Smoking: Tobacco use increases the risk of cellular abnormalities.
• Immune suppression: Conditions or medications that weaken the immune system.
• Long-term oral contraceptive use: Prolonged use may slightly elevate risk.
• Multiple sexual partners: Higher exposure to HPV and other infections.

Symptoms

• Often asymptomatic and detected via screening.
• Abnormal vaginal bleeding (e.g., between periods or after intercourse).
• Unusual vaginal discharge.
• Pelvic pain (rare, may indicate advanced changes).

Diagnosis

Diagnosis typically involves a Pap test (Pap smear) to identify abnormal cells, followed by a colposcopy with biopsy to examine tissue samples. HPV testing may also be performed to assess risk. Additional imaging or procedures are rarely needed unless cancer is suspected.

Treatment Options

• Monitoring: For mild dysplasia (e.g., low-grade squamous intraepithelial lesion), regular follow-up may be sufficient.
• Cryotherapy or laser therapy: Destroys abnormal cells for moderate dysplasia.
• Loop electrosurgical excision procedure (LEEP): Removes abnormal tissue for higher-grade changes.
• Cone biopsy: Excises a cone-shaped section of the cervix for severe cases or when cancer is suspected.

Prognosis and Follow-Up

With appropriate treatment, the prognosis is generally favorable, and most cases do not progress to cancer. Follow-up typically includes repeat Pap tests or HPV testing at intervals determined by the severity of dysplasia. Long-term monitoring is essential to detect recurrence or progression.

Complications

• Progression to cervical cancer if left untreated or undetected.
• Bleeding or infection related to treatment procedures.
• Psychological distress from diagnosis or ongoing monitoring.

Lifestyle & Prevention

• HPV vaccination: Reduces risk of infection with high-risk HPV types.
• Regular screening: Adhere to recommended Pap test intervals.
• Smoking cessation: Lowers the risk of cellular abnormalities.
• Safe sexual practices: Reduces exposure to HPV and other infections.

When to Seek Professional Help

• Abnormal vaginal bleeding or discharge.
• Persistent pelvic pain.
• Results of a Pap test indicating abnormal cells.
• Concerns about HPV infection or cervical health.

Tips for Medical Coders

Document the specific grade or type of dysplasia (e.g., mild, moderate, severe) when available, as this may influence coding specificity. Note any associated procedures (e.g., colposcopy, biopsy) or follow-up care. Ensure documentation supports the clinical context to align with coding guidelines for N87.